Review: taking Levaquin and Miralax together


Summary

Drug interactions are reported among people who take Levaquin and Miralax together. This review analyzes the effectiveness and drug interactions between Levaquin and Miralax. It is created by eHealthMe based on reports of 593 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Levaquin and Miralax >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Levaquin

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. (latest outcomes from Levaquin 28,494 users)

Miralax

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. (latest outcomes from Miralax 8,713 users)

On Jul, 30, 2016

593 people who take Levaquin, Miralax are studied.


Number of reports submitted per year:

Levaquin and Miralax drug interactions.

Drug effectiveness over time:

Levaquin:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Miralax:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Levaquin:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 1 people)
Miralax:
  • female: 0.0% - (0 of 1 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Levaquin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Miralax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • pyrexia
  • abdominal pain
  • neutropenia
  • hyperbilirubinaemia
  • neutropenic infection
  • injury
  • alopecia
  • anxiety
  • arthralgia
  • blister
1 - 6 months:
  • sepsis
  • acute graft versus host disease
  • acute graft versus host disease in skin
  • anaemia
  • cholestasis
  • cytomegalovirus enterocolitis
  • disseminated intravascular coagulation
  • duodenitis haemorrhagic
  • febrile neutropenia
  • gastrointestinal haemorrhage
6 - 12 months:
  • arthritis
  • cardiac disorder
  • constipation
  • dizziness
  • erectile dysfunction
  • gastrooesophageal reflux disease
  • hypersensitivity
  • nervousness
  • osteomyelitis
  • osteonecrosis
1 - 2 years:
  • abdominal distension
  • abdominal pain
2 - 5 years:
  • osteomyelitis
  • osteonecrosis
  • arthritis
  • cardiac disorder
  • constipation
  • dizziness
  • erectile dysfunction
  • gastrooesophageal reflux disease
  • hypersensitivity
  • nervousness
5 - 10 years:
  • insomnia
  • migraine
not specified:
  • pain
  • anxiety
  • injury
  • back pain
  • anaemia
  • dyspnoea
  • osteonecrosis of jaw
  • nausea
  • fatigue
  • constipation

Most common drug interactions by gender *:

female:
  • anxiety
  • pain
  • back pain
  • injury
  • dyspnoea
  • constipation
  • osteonecrosis of jaw
  • pyrexia
  • pain in extremity
  • anaemia
male:
  • pain
  • anxiety
  • injury
  • anaemia
  • asthenia
  • nausea
  • pneumonia
  • fatigue
  • back pain
  • dizziness

Most common drug interactions by age *:

2-9:
  • depression
  • epistaxis
  • febrile neutropenia
  • pancreatitis
  • weight decreased
  • atelectasis
  • bk virus infection
  • haematocrit decreased
  • haemoglobin decreased
  • urinary tract infection
10-19:
  • pulmonary embolism
  • injury
  • pain
20-29:
  • pulmonary embolism
  • injury
  • pain
  • anxiety
  • deep vein thrombosis
  • pleural effusion
  • sepsis
  • anaemia
  • gastrointestinal haemorrhage
  • headache
30-39:
  • back pain
  • pain in extremity
  • pneumonia
  • pain
  • bone pain
  • abdominal pain upper
  • anxiety
  • compression fracture
  • discomfort
  • fatigue
40-49:
  • nausea
  • anxiety
  • constipation
  • injury
  • pain
  • osteonecrosis of jaw
  • hypertension
  • oedema peripheral
  • pyrexia
  • dyspnoea
50-59:
  • pain
  • anxiety
  • back pain
  • injury
  • intervertebral disc protrusion
  • osteoarthritis
  • arthralgia
  • pyrexia
  • hypoaesthesia
  • muscular weakness
60+:
  • pain
  • anxiety
  • anaemia
  • fall
  • asthenia
  • back pain
  • dyspnoea
  • atrial fibrillation
  • fatigue
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Levaquin and Miralax?

Can you answer these questions?

More questions for: Levaquin, Miralax

You may be interested in these reviews

More reviews for: Levaquin, Miralax

On eHealthMe, Levaquin (levofloxacin) is often used to treat sinusitis. Miralax (polyethylene glycol 3350) is often used to treat constipation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.